Investigating intratumour heterogeneity by single-cell sequencing

Asian Journal of Andrology

Volumn 15, Issue 6, 2013, Pages 729-734

  Ren, Shan Cheng ^a   Qu, Min ^a   Sun, Ying Hao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

clinical applications; intratumour heterogeneity; single cell sequencing

Indexed keywords

ANALYTIC METHOD; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CIRCULATING TUMOR CELL; CLONAL EVOLUTION; COPY NUMBER VARIATION; EARLY DIAGNOSIS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; INTRATUMOR HETEROGENEITY; METASTASIS; PERSONALIZED MEDICINE; PROSTATE CANCER; REVIEW; SINGLE CELL SEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; TUMOR MICROENVIRONMENT;

HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; SINGLE-CELL ANALYSIS;

EID: 84887237209     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2013.106     Document Type: Review

References (47)

1. Brown TM, Fee E. Rudolf Carl Virchow: medical scientist, social reformer, role model. Am J Public Health 2006; 96: 2104-5.
2. Heppner GH, Miller BE. Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev 1983; 2: 5-23.
3. Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978; 38: 2651-60. (Pubitemid 9001502)
4. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R et al. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978; 38: 3174-81. (Pubitemid 9031291)
5. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11. (Pubitemid 33041634)
6. Prosise GL, Bonnet MH, Berry RB, Dickel MJ. Effects of abstinence from smoking on sleep and daytime sleepiness. Chest 1994; 105: 1136-41. (Pubitemid 24112804)
7. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-68.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-5. (Pubitemid 46067311)
9. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-63. (Pubitemid 47175279)
10. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-14. (Pubitemid 351267301)
11. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2011; 2: 162.
12. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-8.
13. Merlo LMF, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006; 6: 924-35. (Pubitemid 44862677)
14. Crespi B, Summers K. Evolutionary biology of cancer. Trends Ecol Evol 2005; 20: 545-52. (Pubitemid 41323711)
15. Shibata D. Cancer. Heterogeneity and tumor history. Science 2012; 336: 304-5.
16. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
17. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-7.
18. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009; 461: 809-13.
19. Yachida S, Jones S, Bozic I, Antal T, Leary R et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-7.
20. Bai H, Wang Z, Chen K, Zhao J, Lee JJ et al. Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. J Clin Oncol 2012; 30: 3077-83.
21. Martins FC, De S, Almendro V, Gonen M, Park SY et al. Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov 2012; 2: 503-11.
22. Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 2013; 110: 4009-14.
23. Xu X, Hou Y, Yin X, Bao L, Tang A et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012; 148: 886-95.
24. Hou Y, Song L, Zhu P, Zhang B, Tao Y et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012; 148: 873-85.
25. Welty CJ, Coleman I, Coleman R, Lakely B, Xia J et al. Single cell transcriptomic analysis of prostate cancer cells. BMC Mol Biol 2013; 14: 6.
26. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PloS ONE 2012; 7: e33788.
27. Ramskold D, Luo S, Wang YC, Li R, Deng Q et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 2012; 30: 777-82.
28. Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med 2011; 3: 31.
29. Dean FB, Nelson JR, Giesler TL, Lasken RS. Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res 2001; 11: 1095-9. (Pubitemid 32834553)
30. Zong C, Lu S, Chapman AR, Xie XS. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012; 338: 1622-6.
31. Lu S, Zong C, Fan W, Yang M, Li J et al. Probing meiotic recombination and aneuploidy of single sperm cells by whole-genome sequencing. Science 2012; 338: 1627-30.
32. Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 2010; 102: 627-37.
33. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 2008; 14: 370-8. (Pubitemid 351226103)
34. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192: 373-82.
35. Joosse SA, Hannemann J, Spotter J, Bauche A, Andreas A et al. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells. Clin Cancer Res 2012; 18: 993-1003.
36. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91. (Pubitemid 39095313)
37. Scher HI, Morris MJ, Larson S, Heller G. Validation and clinical utility of prostate cancer biomarkers. Nat Rev Clin Oncol 2013; 10: 225-34.
38. Naoe M, Ogawa Y, Morita J, Omori K, Takeshita K et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007; 109: 1439-45. (Pubitemid 46466573)
39. Navin N, Kendall J, Troge J, Andrews P, Rodgers L et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-4.
40. Castells M, Thibault B, Delord JP, Couderc B. Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci 2012; 13: 9545-71.
41. O'Connor D, Sibson K, Caswell M, Connor P, Cummins M et al. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia. Br J Haematol 2011; 154: 482-5.
42. Gajria D, Chandarlapaty S. HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies. Expert Rev Anticancer Ther 2011; 11: 263-75.
43. Lasken RS. Single-cell sequencing in its prime. Nat Biotechnol 2013; 31: 211-2.
44. Soon WW, Hariharan M, Snyder MP. High-throughput sequencing for biology and medicine. Mol Syst Biol 2013; 9: 640.
45. Li Y, Xu X, Song L, Hou Y, Li Z et al. Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer. Gigascience 2012; 1: 12.
46. Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ et al. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 2012; 181: 1807-22.
47. Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011; 29: 1120-7.